Albert W. Schömig

Albert W. Schömig's AcademicInfluence.com Rankings

Albert W. Schömig

Engineering

#2653

World Rank

#3613

Historical Rank

Biomedical Engineering

#80

World Rank

#81

Historical Rank

engineering Degrees

Albert W. Schömig

Philosophy

#3970

World Rank

#6319

Historical Rank

Logic

#1535

World Rank

#2312

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Why Is Albert W. Schömig Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Albert W. Schömig's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. (1996) (1687)
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis (2007) (1494)
Patient-specific induced pluripotent stem-cell models for long-QT syndrome. (2010) (1164)
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. (2007) (1078)
Estimated radiation dose associated with cardiac CT angiography. (2009) (992)
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. (2008) (876)
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. (2001) (787)
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction (1999) (787)
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. (2006) (779)
Radiation Dose Estimates From Cardiac Multislice Computed Tomography in Daily Practice: Impact of Different Scanning Protocols on Effective Dose Estimates (2006) (725)
Predictive factors of restenosis after coronary stent placement. (1997) (686)
Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial (2005) (667)
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. (2009) (656)
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement (2010) (593)
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. (2004) (582)
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. (1998) (554)
Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study (2006) (540)
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. (2005) (537)
Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. (1998) (513)
Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. (2000) (498)
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. (2005) (482)
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. (2008) (481)
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. (2003) (480)
Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. (2006) (452)
Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement (2001) (437)
Increased neutrophil-platelet adhesion in patients with unstable angina. (1996) (429)
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. (2008) (428)
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel (2009) (426)
Impact of P‐glycoprotein on clopidogrel absorption (2006) (420)
Vessel size and long-term outcome after coronary stent placement. (1998) (416)
Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial (2001) (408)
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. (1995) (403)
Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. (1997) (398)
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. (2012) (380)
5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. (2010) (378)
Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies (2005) (378)
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. (2007) (370)
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. (2015) (368)
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. (2007) (367)
Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. (2000) (361)
Restenosis after coronary placement of various stent types. (2001) (348)
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. (2008) (344)
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. (2005) (333)
Platelet function in acute myocardial infarction treated with direct angioplasty. (1996) (323)
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial (2009) (323)
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement (2010) (323)
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis (2008) (310)
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel (2004) (302)
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment (2007) (295)
Four‐Year Experience With Palmaz‐Schatz Stenting in Coronary Angioplasty Complicated by Dissection With Threatened or Present Vessel Closure (1994) (293)
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents (2006) (286)
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. (2011) (285)
Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. (1997) (282)
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. (1998) (267)
Catecholamines in myocardial ischemia. Systemic and cardiac release. (1990) (259)
Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. (2000) (258)
Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease. (2009) (258)
Pharmacokinetics of clopidogrel after administration of a high loading dose (2004) (251)
Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. (1999) (243)
Influence of lesion length on restenosis after coronary stent placement. (1999) (236)
Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial. (2010) (235)
Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. (2006) (234)
Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. (2009) (232)
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. (2009) (232)
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. (2006) (220)
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. (2008) (219)
Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (2012) (219)
Impact of a reduced tube voltage on CT angiography and radiation dose: results of the PROTECTION I study. (2009) (216)
Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy (2004) (215)
Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. (1987) (212)
Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. (2000) (212)
Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. (2010) (212)
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. (2010) (209)
A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. (2008) (209)
Risk Stratification After Acute Myocardial Infarction by Heart Rate Turbulence (2003) (208)
Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. (1987) (200)
Vitronectin Receptor (αvβ3) Mediates Platelet Adhesion to the Luminal Aspect of Endothelial Cells Implications for Reperfusion in Acute Myocardial Infarction (1997) (199)
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting. (2011) (198)
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. (2008) (197)
Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. (2000) (195)
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. (2009) (193)
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) (2008) (192)
Intracoronary stenting and risk for major adverse cardiac events during the first month. (1998) (190)
Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. (2001) (187)
Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss (2006) (184)
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. (2009) (182)
Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. (2002) (182)
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial (2004) (180)
Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. (2007) (180)
Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events. (2010) (179)
Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. (2006) (178)
Image quality and radiation exposure with prospectively ECG-triggered axial scanning for coronary CT angiography: the multicenter, multivendor, randomized PROTECTION-III study. (2012) (176)
PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. (1999) (174)
Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. (2012) (172)
Improved noninvasive assessment of coronary artery bypass grafts with 64-slice computed tomographic angiography in an unselected patient population. (2007) (172)
Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. (2004) (171)
A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery Disease (2000) (171)
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial (2011) (170)
Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. (1996) (169)
Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial (2005) (168)
Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. (1996) (166)
Extracellular Matrix Metalloproteinase Inducer Regulates Matrix Metalloproteinase Activity in Cardiovascular Cells: Implications in Acute Myocardial Infarction (2006) (165)
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization. (2004) (163)
TaqMan Systems for Genotyping of Disease-Related Polymorphisms Present in the Gene Encoding Apolipoprotein E (2002) (159)
Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. (1996) (158)
Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. (2011) (154)
Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (2010) (152)
Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. (1981) (151)
Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. (2007) (150)
Influence of stent design on 1‐year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients (2000) (150)
Non-invasive coronary computed tomographic angiography for patients with suspected coronary artery disease: the Coronary Angiography by Computed Tomography with the Use of a Submillimeter resolution (CACTUS) trial. (2007) (150)
Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. (2002) (149)
Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. (2008) (147)
Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. (2002) (147)
Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor &kgr;B-Dependent Inflammation in Monocytes (2008) (143)
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy (2010) (143)
Time Course of Restenosis During the First Year After Emergency Coronary Stenting (1993) (140)
Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. (2005) (138)
Ticagrelor--is there need for a new player in the antiplatelet-therapy field? (2009) (138)
Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention. (2007) (137)
Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. (2005) (136)
A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. (2008) (134)
Induction of cytokine expression in leukocytes in acute myocardial infarction. (1997) (134)
Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis (2003) (133)
Catecholamine release and arrhythmias in acute myocardial ischaemia. (1991) (132)
Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating (2005) (131)
Gender and restenosis after coronary artery stenting. (2003) (131)
Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. (1997) (131)
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting (2009) (131)
Gene Expression Profiling of Human Stent-Induced Neointima by cDNA Array Analysis of Microscopic Specimens Retrieved by Helix Cutter Atherectomy: Detection of FK506-Binding Protein 12 Upregulation (2001) (130)
Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. (2011) (128)
Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. (2000) (127)
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. (2002) (126)
Endothelial‐like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction (2005) (124)
Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. (2004) (124)
Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. (1999) (123)
Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomized, Double-Blind Trial (2010) (123)
2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents. (2010) (121)
Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. (2009) (121)
Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. (2006) (117)
Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. (2004) (116)
Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. (1998) (113)
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. (1996) (113)
Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. (2005) (112)
Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating. (2005) (112)
Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. (2010) (111)
Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart. (1988) (111)
Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. (2007) (111)
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial (2002) (110)
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes (2008) (110)
Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. (1997) (107)
P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose (2005) (107)
Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. (2005) (105)
Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness (2006) (105)
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. (2003) (104)
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). (2008) (104)
Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel : limitations of ST-segment elevation in standard and extended ECG leads. (2001) (103)
Essential myosin light chain as a target for caspase-3 in failing myocardium (2002) (103)
Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes. (2008) (102)
Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: a comparison with stress echocardiography and perfusion scintigraphy. (2000) (101)
Early Resolution of ST-Segment Elevation Correlates With Myocardial Salvage Assessed by Tc-99m Sestamibi Scintigraphy in Patients With Acute Myocardial Infarction After Mechanical or Thrombolytic Reperfusion Therapy (2002) (101)
Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction (2004) (99)
Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. (2006) (99)
Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. (2004) (98)
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. (2001) (98)
Prognostic Value of Coronary Computed Tomographic Angiography in Comparison With Calcium Scoring and Clinical Risk Scores (2011) (98)
Comparison of sequential and helical scanning for radiation dose and image quality: results of the Prospective Multicenter Study on Radiation Dose Estimates of Cardiac CT Angiography (PROTECTION) I Study. (2010) (97)
Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. (1998) (97)
Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. (2004) (97)
Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias. (1999) (96)
Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation (2008) (96)
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. (2007) (95)
Diminished vascular response to noradrenaline in experimental chronic uremia. (1982) (95)
New aspects in ultrasound-guided compression repair of postcatheterization femoral artery injuries. (1994) (94)
Blocking caspase-activated apoptosis improves contractility in failing myocardium. (2001) (93)
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. (2011) (93)
Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial. (1997) (91)
Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. (2000) (91)
Recovery of myocardial perfusion in acute myocardial infarction after successful balloon angioplasty and stent placement in the infarct-related coronary artery. (1997) (90)
Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. (1997) (90)
Prognostic Value of Coronary Computed Tomographic Angiography in Diabetic Patients Without Known Coronary Artery Disease (2010) (89)
Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. (1998) (89)
Relation between plasma fibroblast growth factor‐23, serum fetuin‐A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function (2008) (89)
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stent (2009) (89)
Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. (2005) (89)
A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. (1997) (86)
Operator volume and outcome of patients undergoing coronary stent placement. (1998) (86)
Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment. (1994) (86)
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. (2008) (85)
Changes in membrane glycoproteins of circulating platelets after coronary stent implantation. (1996) (85)
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. (2004) (85)
Management of 219 consecutive cases of postcatheterization pseudoaneurysm. (1997) (84)
Prognostic value of uric acid in patients with acute coronary syndromes. (2012) (84)
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting. (2001) (83)
Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. (1999) (82)
α-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. (1999) (82)
Tissue Factor Cytoplasmic Domain Stimulates Migration by Activation of the GTPase Rac1 and the Mitogen-Activated Protein Kinase p38 (2005) (81)
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel. (2010) (80)
MRI of Coronary Wall Remodeling in a Swine Model of Coronary Injury Using an Elastin-Binding Contrast Agent (2011) (80)
Feasibility of dual-source cardiac CT angiography with high-pitch scan protocols. (2009) (80)
Effect of Glycoprotein IIb-IIIa Receptor Antagonism on Platelet Membrane Glycoproteins after Coronary Stent Placement (1998) (80)
ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. (2010) (79)
Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients (1987) (78)
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. (2001) (78)
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial (2001) (77)
VLA-4 (α4β1) engagement defines a novel activation pathway for β2 integrin–dependent leukocyte adhesion involving the urokinase receptor (2000) (77)
Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system. (2001) (77)
HPA-1 and HPA-3 Polymorphisms of the Platelet Fibrinogen Receptor and Coronary Artery Disease and Myocardial Infarction (2000) (77)
Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline. (1990) (77)
Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. (2003) (76)
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. (2004) (75)
C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. (2004) (73)
Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. (1997) (72)
Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. (2008) (72)
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment (2010) (72)
Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis. (2007) (71)
Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. (2006) (71)
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. (2000) (71)
Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. (1997) (70)
Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. (2005) (70)
Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis. (2003) (69)
Changes in vascular smooth muscle sensitivity to vasoconstrictor agents induced by corticosteroids, adrenalectomy and differing salt intake in rats. (1976) (69)
Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions (2007) (69)
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Patients With Chronic Stable Angina (2005) (68)
Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. (2002) (68)
Circulating homocysteine levels in patients with type 2 diabetes mellitus. (2008) (67)
Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. (2001) (67)
A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. (2004) (66)
Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. (2011) (66)
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. (2004) (66)
Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: A randomized double‐blind controlled trial (2005) (66)
Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. (2009) (65)
Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. (2002) (65)
Differential Effect of β‐Adrenergic Stimulation on the Frequency‐Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293. (1997) (65)
Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. (2000) (65)
A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. (2004) (65)
Outcome after out-of-hospital cardiac arrest in a physician-staffed emergency medical system according to the Utstein style. (2007) (65)
Clinical and angiographic follow‐up after balloon angioplasty with provisional stenting for coronary in‐stent restenosis (1999) (65)
Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. (2000) (64)
Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. (2008) (64)
Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform. (2005) (64)
Association of Transforming Growth Factor-&bgr;1 Gene Polymorphisms With Myocardial Infarction in Patients With Angiographically Proven Coronary Heart Disease (2006) (64)
Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. (2010) (64)
Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial. (2010) (63)
Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. (1995) (63)
Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis (2005) (62)
A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries (2004) (62)
Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. (2001) (61)
Pain Threshold for Low Energy Intracardiac Cardioversion of Atrial Fibrillation with Low or No Sedation (1997) (61)
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy. (2011) (61)
Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. (1995) (61)
Enhanced sympathetic activity caused by salt loading in spontaneously hypertensive rats. (1980) (60)
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. (2001) (59)
Cytochrome P 450 2 C 19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention (2009) (59)
A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment. (2010) (59)
Coagulation Factor Xa Stimulates Interleukin-8 Release in Endothelial Cells and Mononuclear Leukocytes: Implications in Acute Myocardial Infarction (2004) (59)
Delineation of Intra‐Atrial Reentrant Tachycardia Circuits After Mustard Operation for Transposition of the Great Arteries Using Biatrial Electroanatomic Mapping and Entrainment Mapping (2003) (59)
Clopidogrel therapy in patients undergoing coronary stenting: Value of a high‐loading‐dose regimen (2002) (58)
The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. (2009) (58)
Implantation of Accuflex and Strecker stents in malignant bronchial stenoses by flexible bronchoscopy. (1997) (58)
A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. (2004) (57)
Characterization of Paroxysmal and Persistent Atrial Fibrillation in the Human Left Atrium During Initiation and Sustained Episodes (2002) (57)
Everolimus-Eluting Versus Sirolimus-Eluting Stents: A Meta-Analysis of Randomized Trials (2011) (57)
Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. (2006) (56)
No Replication of Association Between Estrogen Receptor &agr; Gene Polymorphisms and Susceptibility to Myocardial Infarction in a Large Sample of Patients of European Descent (2005) (56)
Statin treatment following coronary artery stenting and one-year survival. (2002) (56)
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial. (2008) (56)
Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting (2003) (56)
Association of uric acid with mortality in patients with stable coronary artery disease. (2012) (56)
High-sensitivity troponin T level and angiographic severity of coronary artery disease. (2011) (55)
Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties. (2004) (55)
Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. (1997) (55)
Preoperative bronchoscopic assessment of airway invasion by esophageal cancer: a prospective study. (1998) (55)
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. (2008) (54)
Comparative in‐vitro validation of eight first- and second‐generation quantitative coronary angiography systems (1997) (53)
Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. (1997) (53)
Incomplete Inhibition of Platelet Aggregation and Glycoprotein IIb-IIIa Receptor Blockade by Abciximab: Importance of Internal Pool of Glycoprotein IIb-IIIa Receptors (2000) (53)
Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen. (2001) (52)
A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. (2000) (51)
Five‐year clinical outcomes of a polymer‐free sirolimus‐eluting stent versus a permanent polymer paclitaxel‐eluting stent: Final results of the intracoronary stenting and angiographic restenosis – test equivalence between two drug‐eluting stents (ISAR‐TEST) trial (2013) (51)
Effect of electrode position on outcome of low-energy intracardiac cardioversion of atrial fibrillation. (1997) (51)
Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation (1995) (50)
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention. (2008) (50)
Metabolic requirements for release of endogenous noradrenaline during myocardial ischaemia and anoxia (1987) (50)
Effects of an orally active converting-enzyme inhibitor, SQ 14225, on pressor responses to angiotensin administered into the brain ventricles of spontaneously hypertensive rats. (1979) (49)
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia. (2003) (49)
LocaLisa Catheter Navigation Reduces Fluoroscopy Time and Dosage in Ablation of Atrial Flutter: (2003) (49)
Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. (2000) (48)
Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. (1994) (48)
Contribution of the Sympathetic Nervous System to the Hypertensive Effect of a High Sodium Diet in Stroke‐Prone Spontaneously Hypertensive Rats (1982) (48)
Drug-Eluting Stents in Percutaneous Coronary Intervention (2009) (48)
Effect of myocardial ischemia on stimulation-evoked noradrenaline release. Modulated neurotransmission in rat, guinea pig, and human cardiac tissue. (1993) (48)
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. (2008) (48)
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel. (2005) (48)
Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement: impact of dilation pressures. (1997) (48)
Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials (2012) (47)
Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus (2007) (47)
Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction (2009) (46)
CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. (2002) (46)
Triple antithrombotic management after stent implantation: when and how? (2009) (46)
No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting (2012) (46)
Platelet function in clopidogrel-treated patients with acute coronary syndrome (2007) (45)
Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial. (2003) (45)
Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. (2003) (45)
Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. (2004) (44)
Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart. (1996) (44)
Suppression of neointimal thickening and smooth muscle cell proliferation after arterial injury in the rat by inhibitors of Na(+)-H+ exchange. (1993) (44)
Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease (2012) (43)
Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. (2013) (43)
Uric acid and prognosis in angiography‐proven coronary artery disease (2013) (43)
alpha-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. (1999) (43)
ABO locus O1 allele and risk of myocardial infarction (2004) (42)
Long-term outcome after coronary stenting (2000) (42)
The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT. (2013) (41)
Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes (2009) (41)
Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi. (2014) (41)
Cardiovascular risk assessment based on the quantification of coronary calcium in contrast-enhanced coronary computed tomography angiography. (2012) (41)
Turbulence dynamics: an independent predictor of late mortality after acute myocardial infarction. (2006) (41)
Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy. (2012) (40)
Recruitment of Chlamydia pneumoniae–Infected Macrophages to the Carotid Artery Wall in Noninfected, Nonatherosclerotic Mice (2003) (40)
Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials (2010) (40)
Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. (2007) (40)
Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart (2004) (40)
Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials (2011) (40)
The Role of Catecholamines in Ischemia (1990) (39)
Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients (2010) (39)
Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence. (2008) (38)
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. (1994) (38)
Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial. (2007) (38)
Adrenergic Mechanisms in Myocardial Infarction: Cardiac and Systemic Catecholamine Release (1988) (38)
Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement. (2003) (38)
Electrophysiologic characteristics of paroxysmal and chronic atrial fibrillation in human right atrium. (2001) (37)
Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement (2007) (37)
Paradoxical Role of Neuronal Uptake for the Locally Mediated Release of Endogenous Noradrenaline in the Ischemic Myocardium (1985) (36)
Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial (2007) (36)
Non-invasive imaging of glycoprotein VI binding to injured arterial lesions (2005) (36)
Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions (2006) (36)
Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention (2009) (36)
Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents. (2005) (36)
Enhancement of mitral regurgitation and normal left atrial color Doppler flow signals with peripheral venous injection of a saccharide-based contrast agent. (1993) (36)
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. (2003) (35)
Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Pooled Analysis from the ACUITY and ISAR-REACT 4 Trials (2012) (35)
Novel Role of the CXC Chemokine Receptor 3 in Inflammatory Response to Arterial Injury: Involvement of mTORC1 (2009) (35)
Quinapril therapy in patients with chronic mitral regurgitation. (1994) (35)
Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action. (1991) (35)
Comparative efficacy of 2 zotarolimus-eluting stent generations: resolute versus endeavor stents in patients with coronary artery disease. (2013) (35)
Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography (2014) (34)
Computer-assisted animation of atrial tachyarrhythmias recorded with a 64-electrode basket catheter. (1999) (34)
Response to Letter Regarding Article, “Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement” (2010) (34)
Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. (1996) (34)
Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis. (2000) (34)
N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. (2006) (34)
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. (2005) (34)
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet vasodilator-stimulated phosphoprotein flow cytometry (2010) (34)
Proteolysis of Tissue Factor Pathway Inhibitor-1 by Thrombolysis in Acute Myocardial Infarction (2002) (33)
Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells. (2000) (33)
Prognostic value of coronary computed tomographic angiography in asymptomatic patients. (2010) (33)
Regional pre‐ and postsynaptic sympathetic system in the failing human heart — regulation of βARK‐1 (2000) (33)
Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement. (2000) (33)
Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. (2005) (32)
Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. (2010) (32)
Reimplantation of an infected, abdominally implanted defibrillator in the subpectoral region. (1996) (32)
Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease. (2005) (32)
Effects of cocaine and desipramine on the neurally evoked overflow of endogenous noradrenaline from the rat heart (1983) (32)
The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. (2004) (32)
G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease. (2003) (32)
No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population (2007) (32)
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. (2009) (32)
Myocardial perfusion scintigraphy to evaluate patients after coronary stent implantation. (1998) (32)
A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. (2013) (32)
Brain angiotensin II stimulates release of pituitary hormones, plasma catecholamines and increases blood pressure in dogs. (1980) (32)
Altered Transient Outward Current in Human Atrial Myocytes of Patients with Reduced Left Ventricular Function (2000) (31)
Reversal of corticosterone-induced supersensitivity of vascular smooth muscle to noradrenaline by arachidonic acid and prostacyclin. (1980) (31)
Role of calcium channels and protein kinase C for release of norepinephrine and neuropeptide Y. (1990) (31)
Dissociation Between Coronary Sinus and Left Atrial Conduction in Patients with Atrial Fibrillation and Flutter (2001) (31)
Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials (2008) (30)
N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. (2006) (30)
Interaction between the release of adenosine and noradrenaline during sympathetic stimulation: a feed-back mechanism in rat heart. (1989) (30)
Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. (2008) (30)
Randomised comparison of manual compression repair versus ultrasound guided compression repair of postcatheterisation femoral pseudoaneurysms (2006) (30)
Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality. (2010) (30)
Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case-control study and a meta-analysis. (2010) (30)
Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. (2004) (30)
A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib. (2005) (30)
Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B. (1997) (29)
A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite (2005) (29)
Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. (2007) (29)
Enhancement of monocyte procoagulant activity by adhesion on vascular smooth muscle cells and intercellular adhesion molecule-1-transfected Chinese hamster ovary cells. (1998) (29)
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients (1988) (29)
Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention. (2009) (28)
Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. (2007) (28)
Restenosis rate after intravascular ultrasound-guided coronary stent implantation. (1998) (28)
Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart. (1988) (28)
Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts (1995) (28)
Everolimus-Eluting Versus Sirolimus-Eluting StentsClinical Perspective (2011) (28)
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting. (2011) (28)
Prevention of restenosis by systemic drug therapy: back to the future? (2005) (28)
Vascular Remodeling in Mice Lacking the Cytoplasmic Domain of Tissue Factor (2005) (28)
Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging. (2013) (28)
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high load (1997) (28)
Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus. (2002) (28)
VLA-4 (alpha(4)beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor. (2000) (27)
Acute effects of vasopressin on potassium and water balance in rats with diabetes insipidus. (1974) (27)
Validity of cardiac implantable electronic devices in assessing daily physical activity. (2013) (27)
Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation. (2002) (27)
Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy. (2001) (27)
Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction: prospective study using venous contrast echocardiography (2002) (27)
Clinical and angiographic outcome after stent placement for chronic coronary occlusion. (1998) (27)
Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement. (1999) (27)
Stenting for small coronary vessels: a contestable winner. (2001) (27)
Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors (2010) (27)
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial. (2007) (27)
Effects of α‐ and β‐adrenoceptor blockade on the neurally evoked overflow of endogenous noradrenaline from the rat isolated heart (1984) (27)
Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting. (2004) (26)
Lower Prevalence of the OCT2 Ser270 Allele in Patients with Essential Hypertension (2006) (26)
Acute and Midterm Outcome After MitraClip Therapy in Patients With Severe Mitral Regurgitation and Left Ventricular Dysfunction. (2015) (26)
Adenoviral gene transfer of the human V2 vasopressin receptor improves contractile force of rat cardiomyocytes. (1999) (26)
Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention (2009) (26)
Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. (2009) (26)
Lipoprotein(a) and coronary thrombosis and restenosis after stent placement. (1999) (26)
The chromosome 9p21 region and myocardial infarction in a European population. (2011) (26)
Modulation of sympathetic vascular tone by prostaglandins in corticosterone-induced hypertension in rats. (1979) (25)
One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial (2010) (25)
Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting. (2001) (25)
Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies. (1996) (25)
Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis. (2009) (25)
Local cyclin‐dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug‐ eluting stents to prevent neointima formation following vascular injury (2004) (25)
Efficacy of a new balloon catheter for internal cardioversion of chronic atrial fibrillation without anaesthesia (1998) (25)
Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re liquid-filled balloon. (2001) (25)
Prospective ECG-triggered sequential scan protocol for coronary dual-source CT angiography: initial experience (2009) (25)
G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. (2000) (25)
Trends in radiation protection in CT: present and future status. (2009) (24)
Partial replacement of sodium by potassium in the diet restores impaired noradrenaline inactivation and lowers blood pressure in stroke-prone spontaneously hypertensive rats. (1981) (24)
Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention (2010) (24)
Cardiac noradrenaline release accelerates adenosine formation in the ischemic rat heart: role of neuronal noradrenaline carrier and adrenergic receptors. (1994) (23)
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease. (2011) (23)
Analysis of the P Wave in the Signal‐Averaged Electrocardiogram: Normal Values and Reproducibility (1996) (23)
Haptoglobin gene subtyping by restriction enzyme analysis. (2003) (23)
4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting. (2003) (23)
P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate‐induced platelet activation and aggregation after administration of a single high dose of clopidogrel (2006) (23)
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. (1999) (23)
Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography. (2013) (23)
4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries (2010) (23)
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. (2010) (23)
ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. (2012) (23)
Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells (2005) (23)
Pulmonary Vein Internal Electrical Activity Does Not Contribute to the Maintenance of Atrial Fibrillation (2003) (22)
Hydrogen peroxide for prevention of bacterial growth on polymer biomaterials. (1999) (22)
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials. (2012) (22)
Adrenergic System and Ventricular Arrhythmias in Myocardial Infarction (1989) (22)
Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials. (2009) (22)
Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations. (2004) (22)
Noncontact Mapping‐Guided Ablation of Atrial Flutter and Enhanced‐Density Mapping of the Inferior Vena Caval‐Tricuspid Annulus Isthmus (2001) (22)
Five‐year clinical outcomes of sirolimus‐eluting versus paclitaxel‐eluting stents in high‐risk patients (2011) (21)
Initial experience with implantation of internal cardioverter/defibrillators under local anaesthesia by electrophysiologists. (1996) (21)
Distribution of angiographic measures of restenosis after drug-eluting stent implantation (2009) (21)
Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. (2013) (21)
Genotyping of the angiotensin I-converting enzyme gene insertion/deletion polymorphism by the TaqMan method. (2005) (20)
Nicotine-induced release of noradrenaline and neuropeptide Y in guinea-pig heart: role of calcium channels and protein kinase C (1991) (20)
Variability of Ventricular Premature Complexes and Mortality Risk (1996) (20)
Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation. (1994) (20)
Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population (2008) (20)
Modulation of Sympathetic Vasoconstriction by Potassium (1984) (20)
Microstructuring of stainless steel implants by electrochemical etching (2006) (20)
Ischaemia-Induced Noradrenaline Release Mediates Ventricular Arrhythmias (1989) (19)
Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen. (2001) (19)
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease (2011) (19)
Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement (2001) (19)
Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR‐DIRECT trial) (2004) (19)
Release of chemoattractants and neutrophil activation in acute myocardial infarction immediately after successful recanalization of the infarct-related vessel by angioplasty. (1994) (19)
Doppler energy: a new acquisition technique for the transthoracic detection of myocardial perfusion defects with the use of a venous contrast agent. (1997) (19)
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial. (2013) (19)
The conduction and cardiac sympathetic systems: metabolic aspects. (1985) (18)
ISAR-REACT 3 A : a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention (18)
Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction (2005) (18)
Homocysteine Status and Polymorphisms of Methylenetetrahydrofolate Reductase Are Not Associated With Restenosis After Stenting in Coronary Arteries (2003) (18)
An inward rectifier and a voltage-dependent K+ current in single, cultured pericytes from bovine heart. (2000) (18)
Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes. (2011) (18)
Catecholamines in Myocardial Hypoxia and Ischemia (1981) (18)
Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. (2003) (18)
Distal embolic protection in patients with acute myocardial infarction: attractive concept but no evidence of benefit. (2005) (18)
Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation. (2014) (18)
Mapping and ablation of atrial arrhythmias after surgical correction of congenital heart disease guided by a 64-electrode basket catheter. (2001) (17)
Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats. (1981) (17)
Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis (2008) (17)
Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart (1989) (17)
Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease. (2007) (17)
A Comparative Study of Activity and Dual Sensor: Activity and Minute Ventilation Pacing Responses to Ascending and Descending Stairs (1998) (17)
Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting. (2005) (17)
Pressure dependent release of atrial natriuretic peptide (ANP) in patients with chronic cardiac diseases: does it reset? (1986) (17)
Cardiac involvement in Emery–Dreifuss muscular dystrophy (2005) (16)
Pharmacokinetics of clopidogrel in patients with stent thrombosis (2008) (16)
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting (2013) (16)
Genetic risk factors and restenosis after percutaneous coronary interventions (2000) (16)
Vasopressor systems during smoking in humans. (1984) (16)
Second‐versus first‐generation “Limus”‐eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR‐TEST‐4 trial (2013) (16)
Left Atrial Fibrillation with Regular Right Atrial Activation and a Single Left‐to‐Right Electrical Interatrial Connection: (2000) (16)
Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial). (2002) (16)
Noninvasive localization of accessory pathways in patients with Wolff-Parkinson-White syndrome with the use of myocardial Doppler imaging. (1999) (16)
EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury. (2008) (16)
Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction. (2011) (16)
Calcium Antagonism and Norepinephrine Release in Myocardial Ischemia (1992) (15)
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel (2013) (15)
Interleukin 18 gene variation and risk of acute myocardial infarction. (2011) (15)
Drug-eluting stents is their future as bright as their past? (2007) (15)
[Changes in infectious endocarditis--analysis of a disease picture in the last decade]. (1994) (15)
Assessment of Double Chamber Right Ventricle by Magnetic Resonance Imaging (2002) (15)
Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. (2003) (15)
PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction (2003) (15)
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease. (2006) (14)
Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting. (2001) (14)
Assessment of platelet function in whole blood by multiple electrode aggregometry: transport of samples using a pneumatic tube system. (2009) (14)
Interferon-γ and interferon-γ receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting (2005) (14)
Three‐Dimensional Echocardiographic Optimization Improves Outcome in Cardiac Resynchronization Therapy Compared to ECG Optimization: A Randomized Comparison (2014) (14)
Variations of specific non-candidate genes and risk of myocardial infarction: a replication study. (2011) (14)
Assessment of Isolated Right Ventricular Myocardial Infarction by Magnetic Resonance Imaging (2006) (14)
Intervention-Based Strategy in Patients With Stable Coronary Artery Disease A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary (2011) (14)
Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty. (1993) (14)
906-64 Doppler Tissue Imaging of Left Ventricular Myocardium — Initial Results During Pharmacologic Stress (1995) (14)
Increase of Cardiac and Systemic Catecholamines in Myocardial Ischemia (1989) (14)
Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene (2013) (14)
Sensitive troponin and N‐terminal probrain natriuretic peptide in stable angina (2011) (14)
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis (2012) (13)
Angiographic outcomes with biodegradable polymer and permanent polymer drug‐eluting stents (2011) (13)
Characterization of Onset Mechanism and Waveform Analysis in Patients with Atrial Fibrillation Using a High‐Resolution Noncontact Mapping System (2003) (13)
Are we making efficient use of clopidogrel? (2004) (13)
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease. (2006) (13)
Calcium antagonists and cardiac noradrenaline release in ischemia. (1991) (13)
ADH-induced potassium retention in rats with genetic diabetes insipidus. (1972) (13)
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel (2006) (13)
A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes (2006) (13)
Frequency dependence in the action of the class III antiarrhythmic drug dofetilide is modulated by altering L-type calcium current and digitalis glucoside. (1998) (13)
Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment (2008) (13)
Statin pretreatment and presentation patterns in patients with coronary artery disease. (2013) (13)
Thrombogenicity of stainless steel coronary stents with a completely gold coated surface (1998) (13)
A randomized trial comparing the hand‐mounted JoStent with the premounted Multi‐Link Duet stent in patients with coronary artery disease (2001) (13)
Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function (2008) (13)
Ventilation perfusion scintigraphy and lung function testing to assess metal stent efficacy. (1997) (12)
Acute Beneficial Hemodynamic Effects of a Novel 3D-Echocardiographic Optimization Protocol in Cardiac Resynchronization Therapy (2012) (12)
Effect of neonatal sympathectomy by 6-hydroxydopamine on volume and resistance regulation in stroke-prone spontaneously hypertensive rats. (1979) (12)
P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents (2008) (12)
Combined use of contrast-enhanced 2-dimensional and color Doppler echocardiography for improved left ventricular endocardial border delineation using Levovist, a new venous echocardiographic contrast agent (1997) (12)
Long lesions, long stents and the long process of stent optimization. (1999) (12)
Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue (1996) (12)
[Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes]. (2008) (12)
The Recording of Monophasic Action Potentials with Fractal‐Coated Iridium Electrodes in Humans (2000) (11)
Giant coronary aneurysm obstructing the right heart (2006) (11)
Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample. (2008) (11)
Assessment of Cor Triatriatum Sinistrum by Magnetic Resonance Imaging (2003) (11)
Glycoprotein IIb/IIIa receptor blockade with coronary stent placement. (1998) (11)
951-72 Intravascular Ultrasound Guided Optimized Emergency Coronary Palmaz Schatz Stent Placement without Post Procedural Systemic Anticoagulation (1995) (11)
Penetrating Atherosclerotic Ulcer of the Aortic Arch (2003) (11)
Neutropenia with ticlopidine plus aspirin (1997) (10)
Improved Accelerometer‐Based Rate Adaptive Pacing by Means of Second‐Generation Signal Processing (1996) (10)
Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue. (1997) (10)
Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting Published, JLR Papers in Press, October 1, 2004. DOI 10.1194/jlr.M400148-JLR200 (2004) (10)
Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction (2005) (10)
[Right ventricular involvement in acute myocardial infarction]. (2004) (10)
Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons. (2007) (10)
Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-Sestamibi SPECT (2013) (10)
Relationships between haemodynamic parameters and concentrations of atrial natriuretic peptide in human plasma. (1986) (10)
Influence of High‐Pass Filtering on Noncontact Mapping and Ablation of Atrial Tachycardias (2004) (10)
Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT (2008) (10)
Late constrictive involvement of the pericardium in a case of previous myocarditis. (2004) (10)
[Left ventricular function and activity of vasoconstrictor systems in patients with chronic heart insufficiency]. (1984) (10)
Apolipoprotein E gene ε2/ε3/ε4 polymorphism and myocardial infarction: Case-control study in a large population sample (2008) (10)
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo. (2009) (10)
Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia (2004) (10)
Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention. (2010) (10)
Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction. (2011) (9)
Thirst and Salt Appetite in Experimental Renal Hypertension of Rats (1975) (9)
Evaluation of a new treadmill exercise protocol. (1997) (9)
Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation. A randomized study. (1995) (9)
Sympathetic Vascular Tone in Spontaneously Hypertensive Rats (1978) (9)
Gene Transfer of Heterologous G Protein–Coupled Receptors to Cardiomyocytes: Differential Effects on Contractility (2001) (9)
Rate-independent effects of the new class III antiarrhythmic agent ambasilide on transmembrane action potentials in human ventricular endomyocardium. (1997) (9)
Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents. (2006) (9)
Release and effects of catecholamines in myocardial ischemia (1990) (9)
Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction (2013) (9)
Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats. (1981) (9)
Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy (2009) (9)
Acute Myocardial Infarction : Serial Cardiac MR Imaging Shows a Decrease in Delayed Enhancement of the Myocardium during the 1 st Week after Reperfusion 1 (2009) (8)
Polymer-free sirolimus-eluting versus polymer-based paclitaxel-eluting stents: an individual patient data analysis of randomized trials. (2013) (8)
Endocardial cushion defect in a patient with Crouzon syndrome carrying a mutation in the fibroblast growth factor receptor (FGFR)‐2 gene (2007) (8)
Electrocardiographic algorithm for assignment of occluded vessel in acute myocardial infarction. (2003) (8)
Sustained increased risk of adverse cardiac events over 5 years after implantation of gold‐coated coronary stents (2006) (8)
Images in cardiovascular medicine. Assessment of isolated right ventricular myocardial infarction by magnetic resonance imaging. (2006) (8)
Expression of CXCR4, VLA-1, LFA-3 and transducer of ERB in G-CSF-mobilised progenitor cells in acute myocardial infarction (2010) (8)
Leucine 7 to Proline 7 Polymorphism of the Preproneuropeptide Y Gene is Not Associated with Restenosis after Coronary Stenting (2003) (8)
Serum potassium levels on admission and infarct size in patients with acute myocardial infarction. (2009) (8)
Intracoronary Gallopamil During Percutaneous Transluminal Coronary Angioplasty (1992) (8)
Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus. (2004) (8)
Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention (2010) (7)
TaqMan assays for genotyping of single nucleotide polymorphisms present at a disease susceptibility locus on chromosome 6 (2005) (7)
Iron status and clinical outcome in patients with coronary artery disease after coronary stenting. (2005) (7)
The impact of smoking on the antiplatelet action of clopidogrel in non‐ST‐elevation myocardial infarction patients: results from the ISAR‐REACT 4 platelet substudy (2012) (7)
Is it time to jettison complex mechanical thrombectomy in favor of simple manual aspiration devices? (2010) (7)
Impact of myocardial salvage assessed by (99m)Tc-sestamibi scintigraphy on cardiac autonomic function in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. (2009) (7)
Accuracy of N-Terminal Probrain Natriuretic Peptide to Predict Mortality or Detect Acute Ischemia in Patients with Coronary Artery Disease (2007) (7)
EFFECTS OF NEONATAL SYMPATHECTOMY BY 6‐HYDROXYDOPAMINE ON BLOOD PRESSURE AND INTRAVASCULAR VOLUME IN YOUNG STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS (1983) (7)
Neuropeptide Y and Sympathetic Transmission (1989) (7)
Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting. (2005) (7)
Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction (2011) (7)
Current drug-eluting stents in complex patients and lesions. (2006) (7)
720-6 Stenting for Progressive Dissection During PTCA: Clinical, Angiographic and Intravascular Ultrasound Criteria to Define a Low-risk Group not Requiring Subsequent Anticoagulation (1995) (7)
Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease (2007) (7)
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial (2011) (6)
Determination of prestenotic flow volume using an automated method based on colour Doppler imaging for evaluating orifice area by the continuity equation: validation in a pulsatile flow model (1998) (6)
Acute Electrophysiologic Effects and Antifibrillatory Actions of the Long Linear Lesions in the Right Atrium in a Sheep Model (2000) (6)
Vasopressin in Hyponatremia: What Stimuli? (1986) (6)
Metabolic aspects of compensatory mechanisms in cardiac failure. (1984) (6)
Images in cardiovascular medicine. Assessment of double chamber right ventricle by magnetic resonance imaging. (2002) (6)
Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: role of calcium channels and sodium-proton exchange (1992) (6)
Images in cardiovascular medicine. Assessment of cor triatriatum sinistrum by magnetic resonance imaging. (2003) (6)
Neutrophil hyper‐reactivity after exercise‐induced angina pectoris (1995) (6)
Risk factor analysis for stent occlusion within the first month after successful coronary stent placement (1998) (6)
Population 64-Slice Computed Tomographic Angiography in an Unselected Patient Improved Noninvasive Assessment of Coronary Artery Bypass Grafts With (2011) (6)
Lowering of blood pressure in sodium loaded rats by administration of digoxin antibodies (1982) (6)
Neuropeptide Y–A Marker for Noradrenaline Exocytosis (1990) (5)
Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial (2011) (5)
Diagnostic value of standard and extended ECG leads for the detection of acute myocardial infarction as compared to contrast-enhanced magnetic resonance imaging. (2011) (5)
The only better alternative to rescue percutaneous coronary intervention is primary percutaneous coronary intervention. (2009) (5)
Manual compression repair of post-catheterization femoral pseudoaneurysms: an alternative to ultrasound guided compression repair? (2002) (5)
Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine. (1998) (5)
Prognostic value of coronary computed tomographic angiography in patients with arterial hypertension (2012) (5)
Local growth inhibitory effect of paciltaxel released by a biodegradable stent coating on vascular smooth muscle cells (1998) (5)
Plasma catecholamine levels and vascular response in deoxycorticosterone acetate hypertension of rats. (1980) (5)
Intravascular ultrasound-guided emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation. (1996) (5)
Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes. (2008) (5)
Myocardial gene expression of matched hibernating and control tissue from patients with ischemic left ventricular dysfunction (2008) (5)
Gadolinium-enhanced cardiovascular magnetic resonance for the detection and characterization of Loeffler endocarditis in patients with hypereosinophilic syndrome. (2011) (5)
Functional changes in left ventricular hypertrophy: diagnosis of impaired diastolic function in patients with hypertension (2004) (5)
Effects of hydralazine on sympathetic nervous activity in heart failure (1982) (5)
Recurrence of in‐stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus‐eluting stent (2005) (4)
Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention. (2013) (4)
Dual effect of nicotine on cardiac noradrenaline release during metabolic blockade (1994) (4)
Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary interventions. (2005) (4)
Images in cardiovascular medicine. Subacute thrombotic occlusion and spontaneous recanalization of the right coronary artery after percutaneous coronary intervention for ST-elevation myocardial infarction visualized by coronary angiography and cardiac magnetic resonance imaging. (2007) (4)
Intraoperative Recordings of Monophasic Action Potentials with Chronically Implantable Pacemaker Leads (1998) (4)
Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects. (1998) (4)
Coronary artery stent placement with postprocedural antiplatelet therapy in acute myocardial infarction (1998) (4)
High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring (2013) (4)
731-3 Remodelling of Coronary Arteries After Balloon Angioplasty: In Vivo Documentation in Patients Using Consecutive Intravascular Ultrasound (1995) (4)
ISAR--a story of trials with impact on practice. (2010) (4)
Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release. (1991) (4)
Effects of alpha- and beta-adrenoceptor blockade on the neurally evoked overflow of endogenous noradrenaline from the rat isolated heart. (1984) (4)
Does the renin-angiotensin system contribute to the vascular lesions in renal hypertensive rats? (1976) (4)
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual (2009) (3)
[Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation]. (1997) (3)
Assessment of ventricular filling volumes with an automated color Doppler method: validation in a pulsatile flow model. (2001) (3)
Circulatory response to pressor agents in phosphorous depletion. (1982) (3)
[Flexible bronchoscopic implantation of Accuflex and Strecker stents in malignant bronchial stenoses]. (1999) (3)
Role of angiotensin and sodium intake in cardiac noradrenaline release (1991) (3)
Internal Cardioversion of Atrial Fibrillation with a Single Lead Configuration in a Patient with Massive Diaphragmatic Herniation (1998) (3)
Accidental Transarterial Implantation of Dual Chamber Pacemaker Leads in the Left Ventricle and the Right Coronary Artery (2005) (3)
Peroxisome proliferator-activated receptor γ gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries (2004) (3)
Antiplatelet vs. anticoagulation treatment after intracoronary Palmaz-Schatz stent placement in acute myocardial infarction — A prospective randomized trial (1996) (3)
PROGNOSTIC VALUE OF MICROVASCULAR OBSTRUCTION ASSESSED BY CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IN COMPARISON TO TC99M-SESTAMIBI SPECT IN ACUTE MYOCARDIAL INFARCTION (2011) (3)
Myocardial perfusion in acute coronary syndrome. (1999) (3)
822-1 Oral sirolimus to inhibit-recurrent in-stent stenosis: The randomized, double-blind, placebo-controlled OSIRIS trial (2004) (3)
On the lipid granularity of renomedullary interstitial cells in benign and malignant courses of renal hypertension. (1979) (3)
[Long-term treatment with quinapril in chronic aortic and mitral insufficiency]. (1995) (3)
Extracellular sodium and chloride depletion enhances nonexocytotic noradrenaline release induced by energy deficiency in rat heart (1989) (3)
Characterization and inhibition of beta-adrenergic receptor kinase in intact myocytes. (1997) (3)
Regulation of the intravascular volume and of the total peripheral resistance in spontaneous hypertensive rats. (1979) (3)
Intravascular ultrasound (IVUS) in patients with peripheral arterial occlusive disease (PAOD). (1992) (3)
Does Radiofrequency Catheter Ablation Induce a Deterioration in Sympathetic Innervation? A Positron Emission Tomography Study (1998) (3)
FLUID AND SALT INTAKE DURING THE DEVELOPMENT OF RENAL HYPERTENSION IN RATS (1980) (3)
Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium (2012) (2)
[Acute ischemia of an arm as an unusual manifestation of ergotism]. (1994) (2)
Noradrenaline Release, Metabolism and Myocardial Ischaemia Induced Arrhythmias (1986) (2)
1106-177 Pharmacokinetics of clopidogrel and its active metabolite in human plasma (2004) (2)
Does reducing capacitance have potential for further miniaturisation of implantable defibrillators? (1997) (2)
Comparison between magnetic resonance imaging and single-photon emission tomography for the assessment of myocardial salvage after coronary revascularization in acute myocardial infarction (2012) (2)
Abstract 3315: Systemic Inflammatory Changes After Pulmonary Vein Radiofrequency Ablation do not Alter Stem Cell Mobilization (2006) (2)
1001-8 Long-term results of ISAR-REACT: A randomized trial evaluating Abciximab in patients with elective percutaneous coronary intervention after pretreatment with a high loading dose of clopidogrel (2004) (2)
Application of Right Atrial Contiguous Linear Lesions: An In Vivo Efficacy Validation of Multipolar Ablation Catheters in an Animal Model (2002) (2)
Effect of Gallopamil on Myocardial Ischaemia During Percutaneous Transluminal Coronary Angioplasty (2012) (2)
Images in cardiovascular medicine. Real-time perfusion echocardiography of an intracardiac mass. (2003) (2)
Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction. (2003) (2)
Effects of beta-adrenergic blocking agents on peripheral vascular resistance. (1978) (2)
A multicenter randomized trial comparing five different types of slotted-tube stents (1998) (2)
Common Features of Neuropeptide Y and Noradrenaline Release in Guinea Pig Heart (1990) (2)
A Statistical Model for Risk Stratification on the Basis of Left Ventricular Ejection Fraction and Heart-Rate Turbulence (2000) (2)
Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus (2021) (2)
Myocardial Salvage after Reduced-Dose Thrombolysis Combined with Glycoprotein IIb/IIIa Blockade Versus Thrombolysis Alone in Patients with Acute Myocardial Infarction (2004) (2)
YI1-4: Deceleration capacity of heart rate as a predictor of late mortality after myocardial infarction (2006) (2)
Erratum to: Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction (2012) (2)
A patient with angina at night: core curriculum chapters 3 (non-invasive imaging) and 9 (chronic ischaemic heart disease) (2012) (2)
Evidence for nonexocytotic noradrenaline release in human cardiac tissue (1990) (2)
Abstract 28: A Prospective and Randomized Trial to Compare a Left Ventricular Assist Device (Impella LP2.5) With IABP in Patients With Cardiogenic Shock by Acute Myocardial Infarction: The ISAR-SHOCK Trial (2007) (2)
Restenosis in one lesion in patients with multilesion stenting occurs even when the companion lesion is free of restenosis (2001) (2)
Effect of Vasodilator Therapy on Sympathetic Activity in Patients with Impaired Left Ventricular Function (1981) (2)
Subacute Thrombotic Occlusion and Spontaneous Recanalization of the Right Coronary Artery After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Visualized by Coronary Angiography and Cardiac Magnetic Resonance Imaging (2007) (2)
Contrast color Doppler-echocardiography (1993) (1)
[The effect of etilefrine and dihydroergotamine on sympathetic nervous system activity when standing up (author's transl)]. (1978) (1)
Modulation of potassium-evoked exocytotic co-release of noradrenaline and neuropeptide Y by cardiac energy depletion (1991) (1)
Mitral-Valve Endocarditis (2001) (1)
Abstract 2147: Drug-Eluting Stents Versus Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction: A Pooled Patient-Level Analysis of 7 Randomized Trials. (2007) (1)
Glycoprotein IIIa PIA polymorphism and early outcome after coronary stenting in patients with adjunctive abciximab therapy (2003) (1)
Digitalis glycosides enhance cardiac noradrenaline release by a dual mechanism of action (1990) (1)
Abstract 3914: The Novel Identified Platelet Receptor Emmprin (CD147/Basigin) Induces Platelet-Monocyte Interaction In Vivo And Augments Monocyte Recruitment To The Vascular Wall (2008) (1)
Desipramine Inhibits the Nicotine-Induced Exocytosis in Rat Phaeochromocytoma Cells (PC12) (1991) (1)
Features of neuropeptide Y and noradrenaline co-release in guinea-pig heart (1990) (1)
[Advanced heart failure: possible role of endothelin for renal failure; baroreceptor mechanism of vasopressin (AVP) stimulation in advanced heart failure and hyponatremia]. (1991) (1)
Spectrotemporal Mapping of High‐Resolution ECGs in Experimental Myocardial Infarction: Comparison with Time‐Domain Analysis and Epicardial Electrograms (1999) (1)
[Acute vision loss cause by iridocyclitis in a 66-year-old patient with progressive exertional dyspnea]. (1996) (1)
[Cardiac pacemaker and internal defibrillators (ICD). Basic principles and new important developments, status 1998]. (1998) (1)
Recovery of stimulation-evoked noradrenaline release during reperfusion after acute ischemia in rat hearts (1992) (1)
Structural failure of a coronary stent (2001) (1)
[New developments in therapy of unstable angina pectoris]. (1998) (1)
Assessment of coronary flow reserve after stent implantation using positron emission tomography (1996) (1)
Abstract 4486: Stent Thrombosis After Drug-Eluting Stent Implantation: Incidence, Timing and Relation to Discontinuation of Clopidogrel Therapy Over a 4-Year Period (2008) (1)
Stent placement in long (≥15 mm) coronary lesions (1998) (1)
Abstract 12911: Has Low Attenuation Plaque Volume in Coronary Computed Tomographic Angiography an Incremental Value For Prediction of Cardiac Events? (2010) (1)
Abstract 3799: Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions (2006) (1)
Coronary Artery Disease Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main (2009) (1)
Radiation exposure and dose reduction measures in cardiac CT (2008) (1)
Different effects of β-adrenergic stimulation on the prolongation of action potential by Dofetilide and Ambasilide (1996) (1)
Abstract 2599: Proteomic Profiling of Plasma Samples in Coronary Artery Disease (2007) (1)
Preinterventional levels of C-reactive protein and platelet function in patients with stable angina (2003) (1)
Unusual use of a standard percutaneous transluminal coronary angioplasty balloon catheter to the rescue. (2008) (1)
Sympathischer Gefäßtonus bei β-Blockade (1977) (1)
Abstract 1933: Correlates of Bleeding After a 600 mg Loading Dose of Clopidogrel, With and Without Abciximab: A Pooled Analysis of 4 ISAR Randomized Trials. (2007) (1)
Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction (2006) (1)
Inhibition of the renin-angiotensin-system in brattleboro rats with hereditary hypothalamic diabetes insipidus (2005) (1)
Acute coronary artery stent thrombosis following rapid renewal of functional platelets: Implications for intensified antiplatelet therapy (2006) (1)
A recombinant, CMV promotor-driven G protein-coupled receptor in cardiomyocytes is not downregulated by agonists (1998) (1)
[Sympathetic vascular tonus in beta blockade]. (1977) (1)
[Problems of electrocardiographic diagnosis of occlusion of the left circumflex coronary artery]. (2001) (1)
Efficacy of reperfusion with primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction (2011) (1)
SUPPLEMENTAL MATERIAL No Association of ABCB 1 C 3435 T Genotype with Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting (2012) (1)
Contrast-enhanced color Doppler in the assessment of mitral regurgitation (1993) (1)
Effect of nicotine on biological systems (1991) (1)
[Presynaptic regulation of co-release of neuropeptide Y and noradrenaline induced by electrical stimulation of the sympathetic nerve in guinea pig heart]. (1991) (1)
IMPACT OF CALCIUM CHANNEL BLOCKERS ON THE PHARMACODYNAMIC EFFECT AND THE CLINICAL EFFICACY OF CLOPIDOGREL AFTER DRUG ELUTING STENTING (2011) (0)
DIFFERENTIAL VASCULAR HEALING PATTERNS WITH RAPID ABSORPTION BIODEGRADABLE POLYMER SIROLIMUS-ELUTING STENTS VERSUS DURABLE POLYMER EVEROLIMUS-ELUTING STENTS (2012) (0)
[A friend in need is a friend indeed: the case of drug-eluting stents, diabetes and small vessel size]. (2006) (0)
Evaluation ofa NewTreadmill Exercise Protocol (2015) (0)
The authors’ reply: (2009) (0)
Ischemia-induced noradrenaline release and ventricular fibrillation in isolated rat heart (1992) (0)
PIA polymorphism and myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis (2003) (0)
Correlation between T2-weighted CMR and Sestamibi-SPECT in acute myocardial infarction and acute coronary occlusion (2009) (0)
Effect of graded bicycle exercise and cold pressure test on circulating neuropeptide Y: Comparison with noradrenaline (1992) (0)
Stenting for Small Coronary Vessels : A (2016) (0)
[Sympatho-adrenal system in orthostasis]. (1977) (0)
Interferon gamma receptor 1 88 G/A polymorphism and restenosis following coronary artery stenting (2003) (0)
[Regional myocardial perfusion and myocardial function in myocardial infarct with normal coronary angiogram]. (1977) (0)
98. Vitronectin receptor (αv β3) mediates platelet adhesion to the luminal aspect of activated endothelium. Implications for reperfusion in acute myocardial infarction (AMI) (1996) (0)
Contents Vol. 111, 2008 (2008) (0)
Macrolide treatment after coronary stent placement (2001) (0)
Doesreducing capacitance havepotential for further miniaturisation ofimplantable defibrillators (2017) (0)
Novel electrochemical etching technique for microstructuring of stainless steel implants (2005) (0)
Smoking and restenosis after coronary artery stenting: the artifact of smoker's paradox (2002) (0)
TCT-667 Restenosis after coronary stenting in 10,004 patients with follow-up angiography (2012) (0)
Subject Index Vol. 109, 2008 (2007) (0)
ACUTE HEMODYNAMIC OUTCOME AND CLINICAL IMPACT OF PERCUTANEOUS EDGE-TO-EDGE MITRAL VALVE REPAIR USING THE MITRACLIP SYSTEM IN A REAL WORLD SETTING (2011) (0)
Granulocyte colony-stimulating factor and acute myocardial infarction. Authors' reply (2006) (0)
TCT-295 Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed “spread-out neointimal topography”: Results from ISAR-TEST6 OCT trial (2012) (0)
Nicotine-Induced Release of Noradrenaline and Neuropeptide Y in the Heart: Dependence on Calcium, Potassium, and pH (1991) (0)
Effect of dietary sodium and potassium content on sympathetic activity in spSHR (1981) (0)
238 T2-weighted magnetic resonance imaging as marker for area at risk in acute myocardial infarction (2008) (0)
feasibility and safety study: The ACTION trial Actinomycin-eluting stent for coronary revascularization: A randomized (2011) (0)
Abstract 13422: Molecular Imaging of Vascular and Myocardial 18F-FDG Uptake with PET/CT in Patients Early After an Acute Coronary Syndrome (2010) (0)
Long-term outcome after coronary stenting Adnan Kastrati , Donald Hall and Albert Schömig (2016) (0)
Expression of Intercellular Adhesion Molecule-1 on Endothelial Cells Activated Platelets Induce Monocyte Chemotactic Protein-1 Secretion and Surface (1998) (0)
[Possible mechanisms of action of potassium in arterial hypertension]. (1984) (0)
Are sirolimus-eluting stents superior to paclitaxel-eluting stents in patients with small-vessel disease? (2008) (0)
Prognostic value of high-sensitivity cardiac troponin T in patients with stable and unstable coronary artery disease presenting with lowest limit of detection of conventional troponin (2010) (0)
Atrial Natriuretic Peptide (ANP) in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) (1989) (0)
Abstract 1675: Effect of Rosiglitazone versus Placebo on Rapid Angiographic Progression of Non-Culprit Coronary Lesions in Patients with Type 2 DM (2007) (0)
Heart Rate Turbulence: Higher Predictive Value Than Other Risk Stratifiers? (2004) (0)
Direct and indirect catheter-to-catheter carbonization caused by high power radiofrequency delivery via a large tip ablation electrode. (2002) (0)
Images in cardiovascular medicine. Penetrating atherosclerotic ulcer of the aortic arch. (2003) (0)
Antiarrhythmic effects of ACE-inhibitors during myocardial ischaemia? (1990) (0)
Temporal changes of microvascular obstruction and infarct border zone after acute myocardial infarction assessed by contrast enhanced magnetic resonance imaging (2011) (0)
Modulation of protein kinase C activity and ventricular fibrillation in acute myocardial ischemia (1992) (0)
AS-095 Differential Vascular Healing Patterns with Rapid Absorption Biodegradable Polymer Sirolimus-Eluting Stents versus Durable Polymer Everolimus-Eluting Stents (2012) (0)
Drug-Eluting Stents and In-Stent Restenosis—Reply (2005) (0)
Verapamil treatmentafter coronaryangioplasty in patients athighrisk ofrecurrentstenosis (1994) (0)
, Melchior Placement Previous Cytomegalovirus Infection and Risk of Coronary Thrombotic Events After Stent (1999) (0)
Normal values for T2 imaging of acute myocarditis (2010) (0)
EXTENT OF ATHEROSCLEROSIS IRRESPECTIVE OF STENOSIS IS A BETTER OUTCOME PREDICTOR THAN NUMBER OF OBSTRUCTED VESSELS IN INVASIVE CORONARY ANGIOGRAPHY (2011) (0)
Abstract 2531: Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Diabetes Mellitus: Patient-Level Meta-Analysis of Randomized Trials (2008) (0)
CORONARY COMPUTED TOMOGRAPHIC ANGIOGRAPHY IMPROVES RISK PREDICTION FOR SEVERE CARDIAC EVENTS COMPARED TO CLINICAL RISK PREDICTORS AND CALCIUM SCORING (2011) (0)
Erratum to: Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials (2011) (0)
Do unsuccessful subthreshold defibrillation shocks enable subsequent successful defibrillation with lower energy (1996) (0)
Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography (2023) (0)
Postersession V: Hypertonie (1984) (0)
uantitative Measurement of Infarct Size y Contrast-Enhanced Magnetic Resonance maging Early After Acute Myocardial Infarction omparison With Single-Photon mission Tomography Using Tc 99 m-Sestamibi (2016) (0)
Images in cardiology: Structural failure of a coronary stent. (2001) (0)
Reteplase in acute myocardial infarction. Authors' reply (2004) (0)
[Effect of propranolol and bunotrolol on the sympathico-adrenal activity]. (1978) (0)
Subject Index Vol. 111, 2008 (2008) (0)
[Thrombolysis and coronary dilatation in therapy of acute myocardial infarct]. (1994) (0)
Impact of angiographic restenosis detected by routine angiographic follow-up at six months on long-term mortality (2002) (0)
Subject Index Vol. 112, 2009 (2008) (0)
[Ventricular fibrillation and silent myocardial ischemia in a patient without anatomic heart disease]. (1993) (0)
Catecholamine Release in Myocardial Ischemia and Its Clinical Implications (1986) (0)
Abstract 3244: Abciximab Effect on Clinical and Angiographic Restenosis in High-Risk Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Results of the ISAR-REACT 2 Trial (2006) (0)
Sympathetic activity during coronary balloon angioplasty (1991) (0)
[Risk assessment]. (2020) (0)
TCT-673 Drug-eluting stents versus bare metal stents for saphenous vein graft lesions: meta-analysis of randomized trials (2012) (0)
Stent?: Results of the ISAR-PEACE Randomized Trial Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting (2007) (0)
Individaulizable drug-eluting stent system to abgrogate restenosis (ISAR): Preclinical results on feasibility, safety and efficacy of a novel drug-eluting stent system that uses on-site polymer-free rapamycin coating (2004) (0)
[Simplified implantation of defibrillators]. (1995) (0)
Evaluation of the BiodivYsio Stent with matrix HI coating designed for local drug delivery in coronary Arteries: A randomized trial (2003) (0)
Reteplase in Acute Myocardial Infarction—Reply (2004) (0)
[Adenosine--an endogenous protective substance in the heart]. (2008) (0)
Abstract 5216: The Effect of Erythropoietin on Restenosis in Patients With Acute Myocardial Infarction Undergoing PCI (2009) (0)
What is established in thrombolytic therapy of acute myocardial infarction? Pharmacological approaches (1988) (0)
Abstract 3054: Comparison of Overlapping Non-Polymer versus Polymer-Based DES: Finding a Better Balance Between Neointimal Suppression and Arterial Healing (2006) (0)
acute myocardial infarction Urokinase receptor surface expression regulates monocyte adhesion in (2013) (0)
[Value of intravascular ultrasound for therapy follow-up of various angioplasty procedures of peripheral arteries]. (1991) (0)
1121-50 Peroxisome proliferator-activated receptor gamma gene polymorphisms and risk of restenosis after coronary artery stenting in patients with diabetes (2004) (0)
Vessel size, stent strut thickness, and restenosis after coronary stent placement: A subgroup analysis of the randomized ISAR-STEREO-2 trial (2003) (0)
[Adenosine in the heart: an endogenous protective system]. (1994) (0)
Good medicines for bad genes. (2001) (0)
COATINGS WITH BODEGRADABLE ELASTOMER AND RELEASABLE TAXANE AGENT (2017) (0)
[Modification of genetic hypertension in rats]. (1977) (0)
Age dependent impact of the 894 TT genotype of the endothelial nitric oxide synthase on the outcome in men following coronary stent placement (2002) (0)
Abstract 12407: Three Dimensional and Doppler Echocardiographic Parameters Predict Response to Cardiac Resynchronization Therapy (2012) (0)
Abstract 3342: Adequacy of Inclusion of Post-Procedural Bleeding in a Composite End Point for Assessment of Outcome After Percutaneous Coronary Intervention. (2007) (0)
Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction (2012) (0)
Metabolic and sympathetic effects of intracoronary gallopamil during coronary balloon angioplasty (1992) (0)
Images in clinical medicine. Mitral-valve endocarditis. (2001) (0)
Structure recognition in motion pictures with methods of nonlinear dynamics (1996) (0)
CLINICAL RESEARCH Acute Coronary Syndromes Gender and Myocardial Salvage After Reperfusion Treatment in Acute Myocardial Infarction (2005) (0)
[New intervention procedures: lasers, atherectomy, stents]. (1993) (0)
[Regional myocardial perfusion and myocardial function--results of a new nuclear medicine procedure]. (1976) (0)
Stent or percutaneous transluminal coronary angioplasty for occluded coronary arteries in patients with acute myocardial infarction ineligible for thrombolysis (STOPAMI-3) trial (2003) (0)
Can myocardial infarct size be limited pharmacologically? (1986) (0)
Risk for procedural failure of coronary stent placement (1998) (0)
Implantation Myocardial Perfusion Scintigraphy to Evaluate Patients After Coronary Stent (2006) (0)
Effect of PCI on quality of life in patients with stable coronary disease, W.S. Weintraub, J.A. Spertus, P. Kolm, in: N Engl J Med, 359. (2008), 677 (2008) (0)
878-3 Subgroup analysis of the impact of the glycoprotein IIb/IIIa inhibitor abciximab in patients undergoing elective stent placement >2 hours after treatment with a 600 milligram loading dose of clopidogrel: Results from the ISAR REACT trial (2004) (0)
Synthesis and application of a fluorescent deriavte of rapamycin (2005) (0)
Mechanical Reperfusion More Than 12 Hours After Acute Myocardial Infarction—Reply (2005) (0)
[Examination of peripheral arteries with intravascular ultrasound. The informative value and limits of the method in comparison with angiography]. (1991) (0)
Implant à revêtement multiple (2006) (0)
Contrast color Doppler-echocardiography improved diagnosis of mitral and tricuspid regurgitation (1993) (0)
Contents Vol. 109, 2008 (2007) (0)
Residual Tc-99m sestamibi uptake predicts myocardial salvage in patients undergoing rescue angioplasty after failed thrombolysis in acute myocardial infarction (1999) (0)
Comparison between single shot ir-steady state free precession and conventional ir-fast gradient echo sequence for automated quantification of the scar size in acute myocardial infarction in daily practice (2009) (0)
Dual effect of nicotine on cardiac noradrenaline release during energy depletion of the heart (1992) (0)
Modulated neurotransmission in rat, guinea pig, and human cardiac tissue Effect of myocardial ischemia on stimulation-evoked noradrenaline release. (2011) (0)
urability of Antirestenotic Efficacy n Drug-Eluting Stents With and ithout Permanent Polymer (0)
Abstract 4310: Impact of Platelet Response to Clopidogrel on Major In-hospital Bleeding Events in Patients Undergoing Coronary Stent Placement (2009) (0)
[Kidney function in heart failure]. (1989) (0)
Abstract 4308: Clopidogrel Response Status Assessed With Multiplate Point-of-Care Analysis and the Incidence and Timing of Stent Thrombosis Over 6 Months Following Coronary Stenting (2009) (0)
Antiplatelet therapy reduced cardiac and noncardiac events after placement of coronary artery stents (1996) (0)
1121-49 Homocysteine levels and methylenetetrahydrofolate reductase polymorphisms are not associated with restenosis after coronary artery stenting (2004) (0)
An inhibitor of Na+,H+ exchange suppresses neointimal thickening after arterial injury in the rat (1992) (0)
Contents Vol. 112, 2009 (2008) (0)
Effects of Hydralazine and Isosorbide Dinitrate on Vasoconstrictor Mechanisms in Patients with Heart Failure (1983) (0)
Response to Letter Regarding Article, “Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention” (2012) (0)
Myocardial Salvage After Reperfusion Therapy in Patients With Acute Myocardial Infarction (2003) (0)
[Increased sensitivity of vascular muscles in renal and corticosterone hypertension]. (1977) (0)
provided with a rough surface stent and its manufacturing method (2002) (0)
Acute Coronary Syndromes ender and Myocardial Salvage After eperfusion Treatment in Acute Myocardial Infarction (2016) (0)
Congestive Cardiomyopathy: Pathophysiological Aspects (1983) (0)
Value of myocardial perfusion imaging for the prediction of restenosis after stent-supported reperfusion therapy for acute myocardial infarction (1999) (0)
[Comparison between argon and excimer laser angioplasty in patients with lesions of the femoral and popliteal arteries: clinical and angiography results after 1 year]. (1993) (0)
Reduction of exercise induced neutrophil activation after sucessful coronary ballon angioplasty (1992) (0)
Abstract 5759: Intramyocardial Application Of Erythropoietin And Expanded Endothelial Progenitor Cells Improve Regional Left Ventricular Function After Induced Myocardial Infarction In Rats (2008) (0)
Do baseline c-reactive protein levels predict myocardial salvage after reperfusion therapy in patients with acute myocardial infarction? (2003) (0)
Response to Aggarwal, Inflammatory response after intervention assesed by serial C-reactive protein measurements correlates with resterosis in patients with coronary stenting (Am Heart J 2005;150:344-50) (2006) (0)
Ephic algorithm for assignment of occluded vessel in acute myocardial infarction (2003) (0)
AbstractsPotassium currents in pericytes from bovine heart (1998) (0)
[Interventional therapy of angina pectoris]. (1991) (0)
The Upfront Risks of Vascular Access Complications (2013) (0)
2022 Sequence optimization for T2 weighted imaging in acute myocardial infarction (2008) (0)
989-59 Platelet-Leukocyte Interaction in Patients with Unstable Angina (1995) (0)
Delayed local depolarisation and repolarization in postinfarction patients caused by impairment of sympathetic innervation (1997) (0)
Assessment of diastolic heart failure by 3D velocity-encoded MR Imaging with retrospective valve tracking (2010) (0)
Drug-eluting versus bare-metal stents in saphenous vein graft lesions – Author's reply (2012) (0)
[Radiofrequency ablation in permanent ectopic left atrial tachycardia]. (1995) (0)
Nicotine-induced noradrenaline and neuropeptide Y release in normoxic and anoxic guinea pig heart (1990) (0)
Potassium Currents in Pericytes From Bovine Heart (1998) (0)
Assessment of infarct size using real-time myocardial contrastechocardiography (2004) (0)
The National Institutes of Health. We Thank Haleh Nadim and Sarah Pihonak for Excellent Technical Help and Elaine Lavelle for Assistance with Data Management. Fetal Nucleated Erythrocytes in Maternal Circulation Do Not Display a Classic Membrane-associated Apopto- Tic Characteristic (phosphatidylser (2003) (0)
[What's new in the treatment of unstable angina pectoris]. (1999) (0)
Rate-independent prolongation of transmembrane action potential by Ambasilide in falling human myocardium (1996) (0)
Prospective randomized trial of antiplatelet vs. anticoagulation treatment after intracoronary Palmaz-Schatz stent placement-6-month follow-up (1996) (0)
1025-42 Abciximab administration for the prevention of angiographic restenosis in small coronary arteries: Results from the randomized ISAR-SMART-2 trial (2004) (0)
Abstract 3684: Reduced Expression of Adhesion Receptors CXCR4, LFA-1 and VLA-4 on G-CSF-mobilized CD34+ Progenitor Cells in Acute Myocardial Infarction (2006) (0)
Molecular imaging of vascular 18F-FDG uptake with PET/CT in patients early after an acute coronary syndrome (2011) (0)
CLINICAL RESEARCH Interventional Cardiology Influence of Treatment Duration With a 600-mg Dose of Clopidogrel Before Percutaneous Coronary Revascularization (2004) (0)
Szintigraphically assessed myocardial salvage in patients with acute myocardial infarction undergoing stent supported angioplasty (1999) (0)
Myocardial perfusion in patients with non-ST-segment elevation acute coronary syndrome assessed with venous contrast echocardiography (2002) (0)
[Nitric oxide donors in therapy of chronic heart failure]. (1997) (0)
Humoral adaptation mechanisms and clinical outcome during vasodilator therapy. (1988) (0)
Peroxisome proliferator-activated receptor γ gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries (2004) (0)
network meta-analysis with and without diabetes: collaborative Drug eluting and bare metal stents in people (2008) (0)
Apolipoprotein E genotype predicts the outcome after coronary artery stenting (2002) (0)
irolimus and Paclitaxel n Polymer-Based Drug-Eluting Stents imilar But Different (2016) (0)
Rapid and Short Communication (2004) (0)
[Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease]. (1997) (0)
Abstract 2810: Impact of Diabetes Mellitus on Clinical and Angiographic Outcomes in the Drug Eluting Stent Era (2006) (0)
The kidney after removal of one renal artery stenosis in the rat. (1976) (0)
Prognostic impact of restoration of the reperfusion at the epicardial artery and tissue levels in patients with acute myocardial infarction (2010) (0)
IMAGING AND DIAGNOSTIC TESTING PROGNOSTIC VALUE OF MICROVASCULAR OBSTRUCTION ASSESSED BY CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IN COMPARISON TO TC99M-SESTAMIBI SPECT IN ACUTE MYOCARDIAL INFARCTION (2011) (0)
Infarction in Patients With Angiographically Proven Coronary Heart Disease 1 Gene Polymorphisms With Myocardial β Association of Transforming Growth Factor (2006) (0)
Beta-adrenergic stimulation accelerates endogenous adenosine release in cardiac energy deficiency (1990) (0)
[Myocardial rupture after myocardial infarct]. (1990) (0)
Impact of electrochemically etched structures on proliferation of cells on stainless steel (2005) (0)
1016-53 An Inexpensive, Easy to Use and Highly Portable Quantitative Angiographic System (1995) (0)
Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction (2012) (0)
Image Quality and Radiation Exposure With a Low Tube Voltage Protocol for Coronary CT Angiography the II (2010) (0)
Expansion behaviour of coronary stents (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Albert W. Schömig?

Albert W. Schömig is affiliated with the following schools:

Albert W. Schömig's Academic­Influence.com Rankings

Why Is Albert W. Schömig Influential?

Albert W. Schömig's Published Works

Published Works

What Schools Are Affiliated With Albert W. Schömig?

Albert W. Schömig's AcademicInfluence.com Rankings